期刊文献+

血清补体Ca^(3+)检测在结肠癌诊断中的价值 被引量:2

下载PDF
导出
摘要 目的评价血清补体Ca^(3+)检测对结肠癌诊断的价值。方法用酶联免疫吸附法检测结肠癌,胃癌,肝癌以及结肠良性疾病患者和健康人的血清补体Ca^(3+)水平。结果结肠癌患者血清补体Ca^(3+)水平是600±189 ng/ml,明显高于其它各组(P<0.05)。结肠良性疾病患者,胃癌,肝癌组血清补体Ca^(3+)水平与健康人比较无统计学差异(P>0.05)。结论血清补体Ca^(3+)检测对结肠癌的诊断具有一定的价值,并且可能具有一定的特异性。
出处 《实用肿瘤学杂志》 CAS 2008年第1期43-44,共2页 Practical Oncology Journal
  • 相关文献

参考文献6

  • 1Habermann JK, Roblick UJ, Luke BT,et al. Increased serum levels of complement Ca^3+ anaphylatoxin indicate the presence of colorectal tumors [ J ]. Gastroenterology ,2006 ; 131 (4) : 1020-1029
  • 2RaiAJ,ChanDW. Cancer proteomics:serum diagnostic for tumor marker discovery[J]. Ann NY Acad Sci.2004;1002:286
  • 3吴健民,主编.免疫检验理论与临床[M].北京:人民卫生出版社,2003;335-347
  • 4Giltnane JM,Rimm DL. Technologu insight :identification of biomarkers with tissue microarray technology [ J ]. Nat Clin Pract Oncol,2004; 1 : 104- 111
  • 5Hugli TE. Structure and function of the anaphylatoxins [ J ]. Springer Semin Immunopathol, 1984; 7:193-219
  • 6Scholz W, Mcclurg MR, Cardenas GJ, et al. CSa-mediated release of interleukin-6 by hunkan monocytes [ J ]. Clin Immunol Immunopathol, 1990; 57:297-307

共引文献4

同被引文献14

  • 1伍治平,陈明清,王熙才,张宏涛,金从国,李强,陈晓群.结直肠癌患者血清VEGF水平变化的临床意义[J].肿瘤防治杂志,2004,11(11):1171-1173. 被引量:1
  • 2周林静,赵长宏,鲁海玲,吕红琼.TFF1和HSP70在结肠癌中的表达及临床意义[J].实用肿瘤学杂志,2007,21(2):111-113. 被引量:4
  • 3Singh N, Chakrabarty S. Induction of CaSR expression circu- ments the molecular features of malignant CaSR null colon cancer cells [ J ]. Int J Cancer, 2013, 133 (10) : 2307 - 2314.
  • 4Edvardsson K, Nguyen - Vu T, Kalasekar SM, et al. Estrogen receptor beta expression induces changes in the microRNA pool in human colon cancer cells[ J ]. Carcinogenesis ,2013, 34(7) :1431 - 1441.
  • 5Cekaite L, Rantala JK, Bruun J, et al. MiR - 9, - 31, and - 182 deregulation promote proliferation and tumor cell surviv- al in colon cancer [ J ]. Neoplasia,2012,14 (9) : 868 - 879.
  • 6Zhang J,Xiao Z,Lai D,et al. miR -21 ,miR - 17 and miR - 19a induced by phosphatase of regenerating liver - 3 pro- mote the proliferation and metastasis of colon cancer[J]. Br J Cancer, 2012,107 ( 2 ) : 352 - 359.
  • 7Kjaer - Frifeldt S, Hansen TF, Nielsen BS, et al. The prog- nostic importance of miR - 21 in stage II colon cancer: a population - based study [J]. Br J Cancer, 2012,107 ( 7 ) :1169 - 1174.
  • 8Hofsli E, Sjursen W, Prestvik WS, et al. Identification of ser- ttm microRNA profiles in colon cancer[J]. Br J Cancer, 2013,108(8) :1712 - 1719.
  • 9Ahmed FE, Amed NC, Vos PW, et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in blood [ J ]. Cancer Genomics Proteomics ,2012,9 (4) : 179 - 192.
  • 10Rossi S, Di NAF, Mestdagh P, et al. microRNAs in colon cancer: a roadmap for discovery [ J ]. FEBS Lett, 2012,586 (19) :3000 -3007.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部